Zunhua Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Middle Cerebral Artery

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Expert opinion on therapeutic patents

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Zeng, Ziwei Zhang, Zhifang Cai, Pei Hu, Zunhua Yang, Yang Wan, Huilan Li, Jian Xiong, Yulin Feng, Yuanying Fang
Synthesis and Neuroprotective Evaluation of Substituted Indanone/Benzofuranone and Piperidine Hybrids. ACS chemical neuroscience 15 (10) (2024)
Qing Zeng, Ziwei Zhang, Zhifang Cai, Pei Hu, Zunhua Yang, Yang Wan, Huilan Li, Jian Xiong, Yulin Feng, Yuanying Fang
Synthesis and Neuroprotective Evaluation of Substituted Indanone/Benzofuranone and Piperidine Hybrids. ACS chemical neuroscience 15 (10) (2024)
Zunhua Yang, Yuqi Ying, Shaobing Cheng, Jiamin Wu, Ziwei Zhang, Pei Hu, Jian Xiong, Huilan Li, Qing Zeng, Zhifang Cai, Yulin Feng, Yuanying Fang
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents. Journal of medicinal chemistry 67 (9) (2024)
Zunhua Yang, Yuqi Ying, Shaobing Cheng, Jiamin Wu, Ziwei Zhang, Pei Hu, Jian Xiong, Huilan Li, Qing Zeng, Zhifang Cai, Yulin Feng, Yuanying Fang
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents. Journal of medicinal chemistry 67 (9) (2024)
Zunhua Yang, Yuqi Ying, Shaobing Cheng, Jiamin Wu, Ziwei Zhang, Pei Hu, Jian Xiong, Huilan Li, Qing Zeng, Zhifang Cai, Yulin Feng, Yuanying Fang
Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents. Journal of medicinal chemistry (2024)
Qing Zeng, Ziwei Zhang, Zhifang Cai, Pei Hu, Zunhua Yang, Yang Wan, Huilan Li, Jian Xiong, Yulin Feng, Yuanying Fang
Synthesis and Neuroprotective Evaluation of Substituted Indanone/Benzofuranone and Piperidine Hybrids. ACS chemical neuroscience (2024)
Huilan Li, Xiaoyu Deng, Ziwei Zhang, Zunhua Yang, Hesong Huang, Xide Ye, Linyun Zhong, Guoliang Xu, Ronghua Liu, Yuanying Fang
Nitric oxide/paclitaxel micelles enhance anti-liver cancer effects and paclitaxel sensitivity by inducing ferroptosis, endoplasmic reticulum stress and pyroptosis. RSC advances 13 (45) (2023)
Huilan Li, Yuanying Fang, Shuchun Guo, Zunhua Yang
GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present). Expert opinion on therapeutic patents 31 (9) (2021)